What are the common pitfalls and variations in interpreting a Technetium 99m (Tc-99m) Ethylene Dicysteine (EC) renal scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Technetium-99m EC Renal Scan: Common Pitfalls and Variations

Overview of Tc-99m EC Characteristics

Tc-99m EC (ethylene dicysteine) is a renal tubular imaging agent that provides similar scintigraphic information to Tc-99m MAG3, with the key advantage of lower hepatobiliary uptake but the critical pitfall of potential gallbladder visualization that can masquerade as an ectopic kidney. 1, 2

Basic Properties and Performance

  • Tc-99m EC is eliminated principally via active tubular transport with a renal extraction ratio of 0.70 2, 3
  • The agent can be easily labeled at room temperature with high radiochemical purity and remains stable for at least 8 hours 2, 4
  • Within 1 hour, approximately 70% of Tc-99m EC is excreted in the urine 2
  • Plasma clearance of Tc-99m EC is approximately 0.75 of OIH clearance, with strict correlation allowing estimation of OIH clearance from EC clearance 2, 3

Critical Pitfalls in Interpretation

Gallbladder Visualization Mimicking Ectopic Kidney

The most significant pitfall is unexpected gallbladder visualization on delayed images, which can be mistaken for an ectopic or hypoplastic kidney. 1

  • Although hepatobiliary excretion of Tc-99m EC is very low and usually does not affect routine image interpretation, gallbladder visualization should always be considered when interpreting EC renograms 1, 2
  • This pitfall is particularly relevant when evaluating suspected ectopic or hypoplastic kidneys 1
  • Physicians must maintain awareness of this possibility to avoid misdiagnosis 1

Dehydration-Related False Positives

  • Dehydration can falsely prolong tracer retention and mimic obstruction or reduced function, creating false-positive results for functional impairment 5
  • Adequate hydration is essential before performing the study, particularly if diuretics are being administered 6

Limitations in Severe Renal Dysfunction

  • Severe renal dysfunction (GFR <15-20 mL/min) limits interpretation due to inadequate tracer uptake and prolonged background activity 5
  • In patients with renal failure, the lower liver activity of Tc-99m EC compared to MAG3 makes it particularly attractive 2

Technical Variations and Considerations

Pharmacokinetic Differences from Other Agents

  • The distribution volume of Tc-99m EC is twice that of Tc-99m MAG3 (20% of body weight) and slightly higher than OIH 2, 3
  • Plasma protein-bound fraction of Tc-99m EC (30-33%) is significantly lower than both Tc-99m MAG3 and OIH (62%) 2, 3
  • Red blood cell binding of Tc-99m EC is almost negligible (5.7%) 2, 3
  • Clearance half-life of Tc-99m EC (98 ± 54 min) is longer than OIH (74 ± 54 min) 3

Imaging Protocol Variations

  • Serial images should be obtained during 20-30 minutes, with time-activity curves generated over each kidney to demonstrate relative uptake and excretion 6, 4
  • The mean time to peak activity for Tc-99m EC is approximately 4.39 ± 0.32 minutes 4
  • Time from peak to 50% activity is approximately 6.93 ± 0.69 minutes 4

Comparative Performance and Clinical Applications

Advantages Over MAG3

  • Lower hepatobiliary uptake makes Tc-99m EC particularly attractive in patients with renal failure 2, 4
  • Simplicity of preparation compared to MAG3 4
  • Negligible uptake in liver and intestines 2

Differential Renal Function Assessment

  • Tc-99m EC demonstrates highly positive correlation (R = 0.91) with Tc-99m DMSA for differential renal function calculation 7
  • The agent can serve as a reliable single-modality study to evaluate renal cortical defects, differential renal function, perfusion, drainage, and indirect evidence of vesicoureteric reflux 7

Limitations in Cortical Defect Detection

  • Renal parenchymal defects located in ventral middle sections may remain undetected with Tc-99m EC scintigraphy 7
  • While Tc-99m DMSA remains the gold standard for evaluating parenchymal abnormalities, Tc-99m EC detected 97 of 99 focal defects in one comparative study 7

Interpretation Guidelines

Obstruction Assessment

  • T1/2 drainage time >20 minutes after furosemide administration indicates obstruction 6, 8
  • Persistent nephrogram without excretion characterizes an obstructive pattern 8, 9
  • Results must be interpreted alongside clinical findings and other imaging studies, as renography is sensitive but often lacks specificity for distinguishing between different causes of renal dysfunction 5, 9

Functional Assessment Parameters

  • Assess relative uptake between kidneys at early time points to evaluate differential function 9
  • Evaluate kidney size, shape, and position on sequential images to detect anatomical abnormalities 9
  • Identify transit abnormalities from renal cortex to renal pelvis and bladder 9

Common Clinical Scenarios

Pediatric Applications

  • In newborns, examinations are frequently delayed until at least 2 months of age due to lower glomerular filtration rates 6
  • Tc-99m EC can be used for evaluation of severe grade 3 and 4 hydronephrosis in infants 6
  • The agent provides information on split renal function and urinary tract drainage based on renal washout curves 6

Surgical Decision-Making

  • Surgical intervention criteria include T1/2 >20 minutes, decreased renal function (<40% differential), deteriorating function (>5% change on consecutive scans), or worsening drainage 6, 8
  • Serial monitoring can track changes in differential renal function over time 6, 8

References

Research

Gall Bladder Activity on Technetium99m-Ethylenedicysteine Renogram Masquerading as Ectopic Kidney.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 2019

Research

Technetium-99m ethylene dicysteine: a new renal tubular function agent.

European journal of nuclear medicine, 2000

Research

Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995

Guideline

Limitations of 99mTc-MAG3 Renal Scintigraphy for ERPF Estimation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Utility of Lasix Renogram in Urinary Tract Obstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Interpreting a DTPA Renogram

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.